Back to Search
NERINGA ZADEIKIS, MD
MD
Infectious Disease Physician
NPI: 1215238316Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
036084932(IL)
Research & Publications (8)
A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia.
PMID 16199249·Clin Ther·2005
4-observational
Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
PMID 15929954·Eur Respir J·2005
3-trial
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
PMID 15712100·Clin Infect Dis·2005
4-observational
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
PMID 15383197·Curr Med Res Opin·2004
3-trial
Levofloxacin efficacy in the treatment of community-acquired legionellosis.
PMID 15189933·Chest·2004
4-observational
Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
PMID 15119993·Curr Med Res Opin·2004
3-trial
High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.
PMID 12955634·Clin Infect Dis·2003
3-trial
Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
PMID 12946763·Urology·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 415 E NORTH WATER ST, # 1304
CHICAGO, IL 60611 - Phone
- (312) 320-3926
Quick Facts
- NPI
- 1215238316
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile